These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 14616426)

  • 1. The involvement of nurses in reporting suspected adverse drug reactions: experience with the meningococcal vaccination scheme.
    Ranganathan SS; Houghton JE; Davies DP; Routledge PA
    Br J Clin Pharmacol; 2003 Dec; 56(6):658-63. PubMed ID: 14616426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reported paediatric adverse drug reactions in the UK 2000-2009.
    Hawcutt DB; Mainie P; Riordan A; Smyth RL; Pirmohamed M
    Br J Clin Pharmacol; 2012 Mar; 73(3):437-46. PubMed ID: 21988288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals.
    McLernon DJ; Bond CM; Hannaford PC; Watson MC; Lee AJ; Hazell L; Avery A;
    Drug Saf; 2010 Sep; 33(9):775-88. PubMed ID: 20701410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing an adverse drug reaction reporting system at a teaching hospital.
    Baniasadi S; Fahimi F; Shalviri G
    Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):408-11. PubMed ID: 18312492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse drug reaction reporting by general medical practitioners and retail pharmacists in Harare--a pilot study.
    Ball D; Tisócki T
    Cent Afr J Med; 1998 Aug; 44(8):190-5. PubMed ID: 10101417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel scheme for the reporting of adverse drug reactions.
    Clarkson A; Ingleby E; Choonara I; Bryan P; Arlett P
    Arch Dis Child; 2001 Apr; 84(4):337-9. PubMed ID: 11259235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adverse drug reactions following immunization in Germany pursuant to the German Infection Protection Act and the German Medicinal Products Act from January 1, 2004 to December 31, 2005].
    Weisser K; Meyer C; Petzold D; Mentzer D; Keller-Stanislawski B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Nov; 50(11):1404-17. PubMed ID: 17999134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spontaneous reporting of adverse drug reactions by nurses.
    Hall M; McCormack P; Arthurs N; Feely J
    Br J Clin Pharmacol; 1995 Aug; 40(2):173-5. PubMed ID: 8562303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse drug reaction reporting by community pharmacists-The barriers and facilitators.
    Hughes ML; Weiss M
    Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1552-1559. PubMed ID: 31131966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in suspected adverse drug reaction reporting via the yellow card scheme in Wales following the introduction of a National Reporting Indicator.
    Deslandes PN; Bracchi R; Jones K; Haines KE; Carey E; Adams A; Walker J; Thomas A; Routledge PA
    Br J Clin Pharmacol; 2022 Aug; 88(8):3829-3836. PubMed ID: 35322450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines.
    Smith CC; Bennett PM; Pearce HM; Harrison PI; Reynolds DJ; Aronson JK; Grahame-Smith DG
    Br J Clin Pharmacol; 1996 Oct; 42(4):423-9. PubMed ID: 8904613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain.
    Sweis D; Wong IC
    Drug Saf; 2000 Aug; 23(2):165-72. PubMed ID: 10945377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007.
    Aagaard L; Weber CB; Hansen EH
    Drug Saf; 2010 Apr; 33(4):327-39. PubMed ID: 20297864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reporting of adverse drug reactions by nurses.
    Morrison-Griffiths S; Walley TJ; Park BK; Breckenridge AM; Pirmohamed M
    Lancet; 2003 Apr; 361(9366):1347-8. PubMed ID: 12711472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of multicomponent meningococcal group B vaccine (4CMenB) in routine infant immunisation in the UK: a prospective surveillance study.
    Bryan P; Seabroke S; Wong J; Donegan K; Webb E; Goldsmith C; Vipond C; Feavers I
    Lancet Child Adolesc Health; 2018 Jun; 2(6):395-403. PubMed ID: 30169281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reporting of adverse drug reactions by hospital doctors and the response to intervention.
    McGettigan P; Golden J; Conroy RM; Arthur N; Feely J
    Br J Clin Pharmacol; 1997 Jul; 44(1):98-100. PubMed ID: 9241104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A distance-learning programme in pharmacovigilance linked to educational credits is associated with improved reporting of suspected adverse drug reactions via the UK yellow card scheme.
    Bracchi RC; Houghton J; Woods FJ; Thomas S; Smail SA; Routledge PA
    Br J Clin Pharmacol; 2005 Aug; 60(2):221-3. PubMed ID: 16042677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of yellow cards (1986): report to the Committee on the Safety of Medicines.
    Bem JL; Breckenridge AM; Mann RD; Rawlins MD
    Br J Clin Pharmacol; 1988 Dec; 26(6):679-89. PubMed ID: 3242573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.